EWA
ALNY icon

EverSource Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

EverSource Wealth Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Sell
531
-109
-17% -$32.9K 0.01% 1125
2026
Q1 		$212K Sell
640
-421
-40% -$143K 0.01% 1019
2025
Q4 		$422K Sell
1,061
-69
-6% -$30.5K 0.02% 597
2025
Q3 		$515K Buy
1,130
+693
+159% +$282K 0.02% 495
2025
Q2 		$143K Sell
437
-18
-4% -$4.98K 0.01% 1023
2025
Q1 		$123K Buy
455
+39
+9% +$10K 0.01% 839
2024
Q4 		$97.9K Buy
416
+93
+29% +$24.5K 0.01% 905
2024
Q3 		$88.8K Buy
323
+25
+8% +$6.51K 0.01% 838
2024
Q2 		$70.8K Buy
298
+24
+9% +$3.79K ﹤0.01% 936
2024
Q1 		$39.4K Buy
274
+60
+28% +$10K ﹤0.01% 1074
2023
Q4 		$41K Buy
214
+184
+613% +$31.3K ﹤0.01% 976
2023
Q3 		$5.31K Sell
30
-73
-71% -$13.9K ﹤0.01% 1682
2023
Q2 		$19.6K Buy
103
+82
+390% +$16.3K ﹤0.01% 1163
2023
Q1 		$4.21K Sell
21
-23
-52% -$4.83K ﹤0.01% 1705
2022
Q4 		$10.5K Sell
44
-3
-6% -$640 ﹤0.01% 1320
2022
Q3 		$10K Buy
+47
New +$8.96K ﹤0.01% 1120
2022
Q1 		– Sell
-7
Closed -$1K – 1697
2021
Q4 		$1K Buy
+7
New +$1.3K ﹤0.01% 1673

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EverSource Wealth Advisors's ALNY Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Alnylam Pharmaceuticals (ALNY) stake by 17% in Q2 2026, selling an estimated $32.9K and leaving 531 shares worth $160K. The position accounts for 0.01% of the portfolio, ranked #1125.

EverSource Wealth Advisors first reported a position in ALNY in Q4 2021 and has held it in 17 quarters since. The position peaked at $515K in Q3 2025. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • EverSource Wealth Advisors held 531 shares of Alnylam Pharmaceuticals worth $160K as of Q2 2026.
  • EverSource Wealth Advisors sold 109 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $32.9K.
  • Alnylam Pharmaceuticals made up 0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1125 holding.
  • EverSource Wealth Advisors first reported a position in Alnylam Pharmaceuticals in Q4 2021 and has held it in 17 quarters since.
  • EverSource Wealth Advisors's Alnylam Pharmaceuticals position peaked at $515K in Q3 2025.
  • 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.